Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:07 AM EDT
334.00quote price arrow up+5.50 (+1.67%)
Volume
57,170
Close
328.50quote price arrow down-7.37 (-2.19%)
Volume
16,973,832
52 week range
54.21 - 362.00

...

Loading . . .
  • Open335.31
  • Day High344.89
  • Day Low318.29
  • Prev Close328.50
  • 52 Week High362.00
  • 52 Week High Date07/26/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20

Key Stats

  • Market Cap131.903B
  • Shares Out401.53M
  • 10 Day Average Volume33.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change214.44

KEY STATS

  • Open335.31
  • Day High344.89
  • Day Low318.29
  • Prev Close328.50
  • 52 Week High362.00
  • 52 Week High Date07/26/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20
  • Market Cap131.903B
  • Shares Out401.53M
  • 10 Day Average Volume33.60M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change214.44

RATIOS/PROFITABILITY

  • EPS (TTM)1.25
  • P/E (TTM)261.92
  • Fwd P/E (NTM)11.02
  • EBITDA (MRQ)672.52M
  • ROE (MRQ)21.84%
  • Revenue (MRQ)2.732B
  • Gross Margin (MRQ)84.44%
  • Net Margin (MRQ)21.89%
  • Debt To Equity (MRQ)4.77%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO6:0106:01
CDC isn't tracking breakthrough delta infections: Gottlieb on Covid

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
284.00-2.26-0.79%
ILMN
Illumina Inc
486.25-5.26-1.07%
GMAB
Genmab A/S
44.05-0.03-0.07%
INCY
Incyte Corp
76.34-0.97-1.25%
CRL
Charles River Laboratories International Inc
392.75-0.52-0.13%